Cannabis Inhaler The World’s First

We Joke About It In The 80s The World’s First Cannabis Inhaler 

We Joke About It In The 80s and now behold the Cannabis Inhaler Cannabis consumption methods are evolving. Not only are the numbers of cannabis supporters going up, but creative innovators around the globe are developing new ideas left and right. From vaporizers to wax, there are now many ways to get high. If you thought you’ve seen it all, though, think again. Now the world has the first-ever cannabis inhaler that goes by the name of Vapen Clear, and there’s nothing else like it. The Vapen Clear looks exactly like your typical inhaler. It acts the same too, but without the albuterol. The Vapen Clear releases the good stuff, aka THC. It packs a powerful 10mg expenditure per puff, which equals to 100 total puffs per cartridge. Unlike your standard vaporizer pen, the Vapen Clear doesn’t heat the THC. Rather, it uses a propellant to blast the medicine directly inside your lungs. Not only is the Vapen Clear the first of its kind, but it also comes in three different designs based on your favorite strain. For example, the “Daytime” inhaler comes with THC from a Sativa strain, because a Sativa produces energy. In like manner, there is the “Nighttime” inhaler that comes with an indica strain to provide a more mellow and chill effect. Then there’s the “Afternoon” inhaler, which provides a steady buzz from a hybrid of the two. The Vapen Clear inhaler comes with its own unique benefits. One of them is its discreetness. When people see an inhaler, they think asthma, not cannabis. Therefore, the chances of someone accusing you of medicating are slim. While many cannabis consumption methods leave a strong odor behind, the Vapen Clear has virtually no smell. Again, the product doesn’t heat the oil, unlike other vaporizers. Speaking of handy, the size of the Vapen Clear inhaler is another plus. In fact, it’s so small that you can carry it with you wherever you go. Whether you slide it into your pocket or drop it into your purse, it’s easy to take. Not to mention, you don’t have to worry about lugging batteries and lighters along with it. So if you are a cannabis connoisseur who stays on-the-go, this product is perfect for you. At present, the Vapen Clear inhaler is only available in Arizona at select centers. If you happen to be an Arizona resident or plan on making the trip, you can find a store using their website’s map. However, if you want one but cannot get it just yet, not to worry. Soon, However, if you want one but cannot get it just yet, not to worry. Soon, Vapen products will be available in California, Colorado, Nevada, Oregon, and Washington.

Tommy Chong cannabis economy

 Tommy Chong cannabis economy all buds are Chong-approved

I know You remember the 78-year-old counterculture icon as the bearded one of the stoner comedy duo Cheech and Chong. In his decades-long career, he's become synonymous with cannabis. In the best of times, he was accepting a Best Comedy Album Grammy for the pair's 1973 album "Los Cochinos." In the worst of times, he was jailed for sending bongs across state lines. Today things are different. Tommy Chong is a lifestyle brand. His company Chong's Choice puts its stamp on pot paraphernalia like THC-infused breath strips, prerolled blunts, oil, and of course, marijuana flowers. The selling point All buds are Chong-approved. "We're having a really good time at least I am testing the different products and seeing the industry grow, no pun intended,"get it?" Chong says he's glad to be done with all the "bogus stuff" he used to deal with. Not to mention, being aboveboard is very good business these days. Case in point: SmokEmojis, Chong's own set of celebrity-inspired emojis. His ultimate goal, aside from advocating about pot, is to make sure it takes only a tap to get your friends together for a toke. Emojis, for the most part, can be very cheerful signs. That's how we communicated before we had the written word. Pot's gotten a lot more mainstream. In fact, you've got a lot of folks in suits investing in it If the demand gets that great, then big business, because we're talking volume. It's like holding an event for 200-300 people. That's easy to do. But an event for 100,000 people then you have to go to big business. You have to have the parking; you have to have the staff to support that type of crowd. It's the same thing as growing marijuana. It'll be big business with a different look. Up until now, the legal money raised from cannabis was usually forfeiture and fines, and penalties laid on by governments and the police. Most of the money, if not all the money, went into prosecuting and investigating more pot crimes [instead of going into the economy]. It's a substance that people use for all types of reasons. It's going to be the No. 1 legal cash crop in the world. It's going to outshine wheat. I can safely say this is going to be the product that will economically save the world places like Michigan. You can turn Hazel Park [Michigan] into one complete grow room and there you're providing employment, you're providing product for the locals as well as exporting, and you're not harming the environment like a lot of the factories did.

#TommyChong #cannabis #economy all #buds are Chong-approved https://t.co/O8gvJhxGJl pic.twitter.com/owodS8YWmb

— 420 Press News (@420_Press_News) August 9, 2016

http://420pressnews.tumblr.com/post/148702768689/tommy-chong-cannabis-economy-all-buds-are

Cannabis effects human skeleton

How Cannabis effects human skeleton

Let`s take a quick peek at how the Cannabinoids gleaned from the cannabis plant work with the human skeletal functions so that you can make informed decisions when it comes to your health and wellness.

Visit us on Facebook

Cannabis Corner Cafe

Cannabis use linked to worse treatment outcomes for PTSD patients

 

Cannabis use for PTSD patients 

Patients experiencing a first episode of psychosis may endure worse treatment outcomes from cannabis use, according to researchers, after finding that such patients are 50% more likely to be admitted to the hospital after initial treatment than non-users.

 Psychosis is a term used to describe symptoms of a mental illness that cause a person to lose touch with reality, such as hallucinations or delusions. These are often symptoms of disorders such as schizophrenia, bipolar or post-traumatic stress disorder (PTSD).

According to the National Alliance on Mental Illness around 3 in every 100 people in the US will experience a psychotic episode some point in their lives, young adults most at risk.

Previous research has suggested cannabis use for individuals are at greater risk of psychotic episodes, particularly if they use the drug in adolescence.

However, study coauthor Dr. Rashmi Patel, of the Department of Psychosis Studies at King's College London in the UK, note that it is unclear whether people who are already experiencing a psychotic episode are at greater risk for relapse as a result of cannabis use.

With a view to finding out, the team analyzed the health records of 2,026 people who had been treated for a first episode of psychosis at the UK's South London and Maudsley (SLaM) National Health Service (NHS) Foundation Trust between 2006-2013.

The researchers assessed patients' cannabis use within a month of their first treatment visit and tracked any subsequent treatment and outcomes for the following 5 years.

More hospital admissions, antipsychotic prescriptions for cannabis use

The health records revealed that around 46.3% of the patients were using cannabis within 1 month of initiating treatment for a first psychotic episode, with use of the drug most common among single men aged 16-25.

Compared with patients who did not use cannabis, those who did were 50% more likely to be readmitted to the hospital in the 5 years after initial treatment; cannabis users had an average of 1.8 hospital admissions over the 5 years, while non-users had an average of 1.2 admissions.

Cannabis users were also more likely to experience compulsory hospital detention under the UK's Mental Health Act, with 45% of users being sectioned, compared with 34% of those who did not use the drug.

Psychosis patients who used cannabis were also at greater risk for longer hospital stays, particularly after completion of 2 years of treatment; compared with non-users, the average hospital stay for those who used cannabis increased from 21 days to 35 days in the 3-5 years after starting treatment.

What is more, the researchers found that cannabis users were more likely to be prescribed a drug called clozapine - commonly used for hard-to-treat schizophrenia - and had a higher number of prescriptions for a range of other antipsychotic medications in the 5 years after first treatment, compared with non-users.

Cannabis use may lead to antipsychotic treatment failure